Bayesian Capital Management, LP Amneal Pharmaceuticals, Inc. Transaction History

Bayesian Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $56,350 - $68,180	10,754 New	10,754 $65,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.38 $67,232 - $104,677	-14,184 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$3.95 - $5.42 $14,615 - $20,054	-3,700 Reduced 20.69%	14,184 $65,000
Q3 2020 Nov 12, 2020	BUY	$3.54 - $5.27 $63,309 - $94,248	17,884 New	17,884 $69,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.19B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.